From the publishers of JADPRO

Graft-vs.-Host Disease Resource Center

Advertisement

Patient-reported outcomes and mortality in cutaneous chronic graft-vs-host disease

Last Updated: Friday, April 26, 2024

Data from a multicenter prospective cohort study showed that cutaneous chronic GVHD was independently associated with long-term patient-reported outcome impairment, with the highest morbidity among those with sclerotic and combination disease. The degree of impairment at GVHD diagnosis was a prognostic marker for mortality.

JAMA Dermatology
Advertisement
News & Literature Highlights
Advertisement
Advertisement